Our study shows that SSTF treatment can reduce schistosomiasis-induced liver fibrosis by downregulating TGF-β1 and upregulating the Smad7 expression in liver tissue, thus preventing TGF-β1 from activating HSCs and reducing the degree of hepatic fibrosis. The gene discussed is TGFB1; the disease is schistosomiasis.